1.86
price up icon3.33%   0.06
after-market After Hours: 1.88 0.02 +1.08%
loading
Stereotaxis Inc stock is traded at $1.86, with a volume of 263.44K. It is up +3.33% in the last 24 hours and down -15.45% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$1.80
Open:
$1.82
24h Volume:
263.44K
Relative Volume:
0.51
Market Cap:
$180.88M
Revenue:
$32.38M
Net Income/Loss:
$-21.64M
P/E Ratio:
-7.3897
EPS:
-0.2517
Net Cash Flow:
$-13.78M
1W Performance:
+3.33%
1M Performance:
-15.45%
6M Performance:
-36.30%
1Y Performance:
-6.06%
1-Day Range:
Value
$1.815
$1.875
1-Week Range:
Value
$1.74
$1.91
52-Week Range:
Value
$1.54
$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name
Name
Stereotaxis Inc
Name
Phone
314-678-6100
Name
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Name
Employee
118
Name
Twitter
@stereotaxis
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
STXS icon
STXS
Stereotaxis Inc
1.86 175.05M 32.38M -21.64M -13.78M -0.2517
ISRG icon
ISRG
Intuitive Surgical Inc
469.98 167.61B 10.06B 2.88B 2.49B 7.876
BDX icon
BDX
Becton Dickinson Co
158.27 44.35B 21.92B 1.76B 2.63B 6.1223
ALC icon
ALC
Alcon Inc
75.26 36.19B 10.40B 980.00M 1.61B 1.9749
MDLN icon
MDLN
Medline Inc
42.67 34.11B 28.43B 1.16B 1.26B 1.4457
RMD icon
RMD
Resmed Inc
226.31 33.24B 5.40B 1.49B 1.78B 10.12

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-16-25 Initiated Citizens JMP Mkt Outperform
Jan-10-24 Initiated ROTH MKM Buy
Jul-12-22 Initiated Aegis Capital Buy
Jun-23-22 Initiated B. Riley Securities Buy
Jan-05-22 Initiated Craig Hallum Buy
Jan-05-22 Initiated Loop Capital Buy
May-26-21 Initiated Piper Sandler Overweight
Sep-08-20 Initiated Northland Capital Outperform
Apr-09-20 Initiated Cowen Outperform
Apr-07-20 Initiated Lake Street Buy
View All

Stereotaxis Inc Stock (STXS) Latest News

pulisher
Mar 23, 2026

Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris - Traders Union

Mar 23, 2026
pulisher
Mar 23, 2026

[EFFECT] Stereotaxis, Inc. SEC Filing - Stock Titan

Mar 23, 2026
pulisher
Mar 20, 2026

Aug Big Picture: Is Stereotaxis Inc being accumulated by smart moneyWeekly Earnings Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 18, 2026

Stereotaxis (STXS) Announces First Robotic MAGiC Sweep Catheter Procedure at Deborah Heart and Lung Center - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview - Traders Union

Mar 17, 2026
pulisher
Mar 16, 2026

Analyst Calls: Can Stereotaxis Inc keep up with sector leaders2026 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 15, 2026

Stereotaxis Inc. (STXS) reports Q4 loss, lags revenue estimates - MSN

Mar 15, 2026
pulisher
Mar 13, 2026

Stereotaxis (NYSE American: STXS) registers $79.6M unsold securities, adds $42.1M ATM balance - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Stereotaxis (STXS) to Participate in BTIG Hosted Virtual Meeting - GuruFocus

Mar 13, 2026
pulisher
Mar 13, 2026

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS) - Seeking Alpha

Mar 13, 2026
pulisher
Mar 13, 2026

Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN

Mar 13, 2026
pulisher
Mar 12, 2026

Stereotaxis Inc. 2025 Annual Report: Robotic Magnetic Navigation Systems, Strategic Partnerships, and Market Overview - Minichart

Mar 12, 2026
pulisher
Mar 12, 2026

Stereotaxis (NYSE: STXS) details 2025 backlog, APT deal and catheter shift - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Stereotaxis 10-K: $32.4M Revenue, $(0.25) EPS - TradingView

Mar 12, 2026
pulisher
Mar 11, 2026

32.4 million revenue surges over 20 percent with regulatory wins, Stereotaxis asserts - Traders Union

Mar 11, 2026
pulisher
Mar 10, 2026

Stereotaxis (STXS) Q4 Earnings: EPS Beats, Revenue Misses - GuruFocus

Mar 10, 2026
pulisher
Mar 10, 2026

Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ... By GuruFocus - Investing.com Canada

Mar 10, 2026
pulisher
Mar 09, 2026

Stereotaxis (STXS) Achieves Regulatory Milestones and Revenue Gr - GuruFocus

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis Q4 Earnings Call Highlights - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - Bitget

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis (STXS) Projects Strong Revenue Growth by 2026 - GuruFocus

Mar 09, 2026
pulisher
Mar 09, 2026

STXS Q4 Revenue Misses Expectations; Strong Backlog Reported - GuruFocus

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis reports 20% revenue growth - The Business Journals

Mar 09, 2026
pulisher
Mar 09, 2026

Surgical robotics firm Stereotaxis Q4 revenue jumps - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis (NYSE: STXS) posts 20% 2025 revenue growth and eyes $40M+ in 2026 - Stock Titan

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis Q4 Earnings Summary & Key Takeaways - Benzinga

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis Reports 2025 Full Year Financial Results - ChartMill

Mar 09, 2026
pulisher
Mar 09, 2026

Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET - Traders Union

Mar 09, 2026
pulisher
Mar 09, 2026

Surgical robotics firm Stereotaxis aims to top $40M revenue in 2026 - Stock Titan

Mar 09, 2026
pulisher
Mar 07, 2026

Aug Weekly: Should I buy Stereotaxis Inc stock nowJuly 2025 Chart Watch & Fast Entry High Yield Tips - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

AI Robot in Heart Treatment Market Is Going to Boom | Major Giants Intuitive Surgical, Stereotaxis, Auris Health - openPR.com

Mar 07, 2026
pulisher
Mar 06, 2026

Stereotaxis (STXS) Set to Release Q4 Earnings with Revenue Growt - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Preview: Stereotaxis's Earnings - Benzinga

Mar 06, 2026
pulisher
Mar 06, 2026

Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update - Defense World

Mar 06, 2026
pulisher
Mar 05, 2026

Treasury Yields: Should value investors consider Stereotaxis IncTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 04, 2026

STXS SEC FilingsStereotaxis Ord 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union

Mar 04, 2026
pulisher
Mar 04, 2026

Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com

Mar 03, 2026
pulisher
Mar 03, 2026

Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - Revista ADVFN

Mar 03, 2026
pulisher
Mar 02, 2026

Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union

Mar 02, 2026
pulisher
Mar 02, 2026

Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat

Mar 02, 2026
pulisher
Feb 24, 2026

STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026
pulisher
Feb 22, 2026

Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru

Feb 22, 2026
pulisher
Feb 20, 2026

Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat

Feb 20, 2026
pulisher
Feb 13, 2026

Fed Watch: Does Stereotaxis Inc align with a passive investing strategyQuarterly Profit Report & Risk Controlled Stock Alerts - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 13, 2026

Will Stereotaxis Inc. stock recover after earningsMarket Volume Summary & Safe Entry Trade Reports - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Why Stereotaxis Inc. stock is favored by top institutionsQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewswire

Feb 12, 2026
pulisher
Feb 12, 2026

Robotic surgery firm Stereotaxis to reveal 2025 results March 9 - Stock Titan

Feb 12, 2026

Stereotaxis Inc Stock (STXS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$64.64
price up icon 0.95%
$180.27
price up icon 0.52%
COO COO
$71.45
price up icon 1.36%
$75.52
price down icon 0.04%
WST WST
$247.02
price up icon 0.71%
RMD RMD
$226.31
price down icon 0.82%
Cap:     |  Volume (24h):